The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia
Open accessAbstract
Objective: The most common neurological symptom of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) is early life refractory epilepsy. As previous studies have shown enhanced excitatory glutamatergic neurotransmission in TSC and FCD brains, we hypothesized that neurons associated with these lesions may also express altered γ‐aminobutyric acid (GABA) A receptor (GABA A R)‐mediated inhibition. Methods: Expression of the GABA A R subunits α1 and α4, and the Na + ‐K + ‐2Cl − (NKCC1) and the K + ‐Cl − (KCC2) transporters, in human TSC and FCD type II specimens were analyzed by Western blot and double label immunocytochemistry. GABA A R responses in dysplastic neurons from a single case of TSC were measured by perforated patch recording and compared to normal‐appearing cortical neurons from a non‐TSC epilepsy case. Results: TSC and FCD type IIb lesions demonstrated decreased expression of GABA A R α1, and increased NKCC1 and decreased KCC2 levels. In contrast, FCD type IIa lesions showed decreased α4, and increased expression of both NKCC1 and KCC2 transporters. Patch clamp recordings from dysplastic neurons in acute slices from TSC tubers demonstrated excitatory GABA A R responses that were significantly attenuated by the NKCC1 inhibitor bumetanide, in contrast to hyperpolarizing GABA A R‐mediated currents in normal neurons from non‐TSC cortical slices. Interpretation: Expression and function of GABA A Rs in TSC and FCD type IIb suggest the relative benzodiazepine insensitivity and more excitatory action of GABA compared to FCD type IIa. These factors may contribute to resistance of seizure activity to anticonvulsants that increase GABAergic function, and may justify add‐on trials of the NKCC1 inhibitor bumetanide for the treatment of TSC and FCD type IIb‐related epilepsy. ANN NEUROL 2012
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excitatory actions of gaba during development: the nature of the nurture
Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448
The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation
Rivera, C., Voipio, J., Payne, J. A., Ruusuvuori, E., Lahtinen, H., Lamsa, K., Pirvola, U., Saarma, M., & Kaila, K. (1999) · Nature · doi:10.1038/16697 · Cited by 2,152 · cited 1×
“In adult neurons, intracellular Cl concentration is maintained at low levels due to the high KCC2 expression; therefore, activation of these receptors results in a net Cl influx and subsequent hyperpolarization.(23) In contrast, immature neurons accumulate Cl due to an age-specific upregulation of NKCC1 and a relative…”
BackgroundIdentification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648 · cited 1×
“TSC is a multiorgan autosomal dominant disorder due to inactivating mutations in the TSC1 and TSC2 genes.(4) In contrast, the various phenotypes of FCD are not associated with consistent genetic mutations, suggesting a role of fetal, perinatal, or early postnatal insults.”
BackgroundExcitatory GABA Action Is Essential for Morphological Maturation of Cortical Neurons In Vivo
Cancedda, L., Fiumelli, H., Chen, K., & Poo, M.-M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5169-06.2007 · Cited by 392
Wang, D. D., & Kriegstein, A. R. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq124 · Cited by 148
TSC1/TSC2 signaling in the CNS
Han, J. M., & Sahin, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.001 · Cited by 105 · cited 1×
“Loss of TSC1/TSC2 function in TSC results in hyperactivation of the mammalian target of rapamycin (mTOR) pathway and subsequent increased protein synthesis and abnormal cellular differentiation and growth.(6,7) Cortical tubers are characterized by areas of disrupted cortical and subcortical architecture, and the prese…”
BackgroundEffect of the α subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptors
Picton, A. J., & Fisher, J. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.050 · Cited by 61
Cited by
Cation-chloride cotransporters in neuronal development, plasticity and disease
Kaila, K., Price, T. J., Payne, J. A., Puskarjov, M., & Voipio, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3819 · Cited by 749
Malformations of cortical development: clinical features and genetic causes
Guerrini, R., & Dobyns, W. B. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70040-7 · Cited by 513
mTOR in Brain Physiology and Pathologies
Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 356
Bateup, H. S., Johnson, C. A., Denefrio, C. L., Saulnier, J. L., Kornacker, K., & Sabatini, B. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.017 · Cited by 330
GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders
Cellot, G., & Cherubini, E. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00070 · Cited by 302
Löscher, W., Puskarjov, M., & Kaila, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.045 · Cited by 271
Deidda, G., Bozarth, I. F., & Cancedda, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00119 · Cited by 192
Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
Salussolia, C. L., Klonowska, K., Kwiatkowski, D. J., & Sahin, M. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015354 · Cited by 163
Mühlebner, A., van Scheppingen, J., Hulshof, H. M., Scholl, T., Iyer, A. M., Anink, J. J., van den Ouweland, A. M. W., Nellist, M. D., Jansen, F. E., Spliet, W. G. M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157396 · Cited by 88
Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Aronica, E., Specchio, N., Luinenburg, M. J., & Curatolo, P. (2023) · Brain · doi:10.1093/brain/awad048 · Cited by 74
The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)
Feliciano, D. M. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00039 · Cited by 69
“There are also significant reductions in GABA receptors in tubers(White et al., 2001; Talos et al., 2012).”
BackgroundSpecchio, N., Nabbout, R., Aronica, E., Auvin, S., Benvenuto, A., de Palma, L., Feucht, M., Jansen, F., Kotulska, K., Sarnat, H., et al. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.08.005 · Cited by 58
Zhang, J., Argueta, D., Tong, X., Vinters, H. V., Mathern, G. W., & Cepeda, C. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1486315 · Cited by 3
Metadata
- Authors
- Talos, D. M., Sun, H., Kosaras, B., Joseph, A., Folkerth, R. D., Poduri, A., Madsen, J. R., Black, P. M., & Jensen, F. E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-03-23
- Volume
- 71
- Issue
- 4
- Pages
- 539-551
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2103738596
- Cited by
- 182
- References
- 7
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.